Hypertension

George L Bakris, MD, is a nephrologist whose specialty is kidney function/disease and hypertension. He has led several large NIH-funded studies resulting in paradigm shifts in blood pressure treatment guidelines for patients with treatable and challenging hypertension. Dr Bakris is Professor of Medicine and Director of the American Heart Association Comprehensive Hypertension Center at the University of Chicago in Chicago, Illinois. Matthew J Sorrentino, MD, a cardiologist whose focus is preventive cardiology, is Professor of Medicine at the Bucksbaum Institute for Clinical Excellence and Vice Chair of Clinical Operations for the Department of Medicine at the University of Chicago. Both Drs Bakris and Sorrentino edited the current edition of Hypertension. Luke J Laffin, MD, is Co-Director of the Center for Blood Pressure Disorders in the Department of Cardiovascular Medicine at Cleveland Clinic in Cleveland, Ohio. Dr Laffin was a contributor on the current edition.

"The book covers the basics, diagnostics, and treatment of hypertension. The accompanying website resource includes the electronic version of the text (eBook) with roughly the same information contained in the main text. The previous edition was published in 2017." ©Doody’s Review Service, 2024, Jonathan Rzonzew, MD Candidate (Universidad San Francisco de Quito) Doody’s Score: 96 - 4 Stars!

• SECTION I: EPIDEMIOLOGY AND PREVENTIVE STRATEGIES1. General Population and Global Cardiovascular Risk Prediction2. Diet and Hypertension3. Exercise and Hypertension4. Hypertension in WomenSECTION II: PATHOPHYSIOLOGY5. Pathophysiology of Hypertension6. Genetics of Hypertension7. Inflammation and Immunity in HypertensionSECTION III: DIAGNOSIS AND EVALUATION8. The Environment and High Blood Pressure9. Office Blood Pressure Measurement10. Home Monitoring of Blood Pressure11. Ambulatory Blood Pressure Monitoring in Clinical Hypertension Management12. White Coat and Masked Hypertension13. Renovascular Hypertension and ISchemic Neuropathy14. Secondary Hypertension: Primary Hyperaldosteronism and Mineralocorticoid Excess States15. Secondary Hypertension: Pheochromocytoma and Paraganglioma16. Sleep Disruption and Blood PressureSECTION IV: RISK STRATIFICATION17. The Natural History of Untreated Hypertension18. Isolated Systolic Hypertension19. Assessment of Hypertension-Mediated Organ DamageSECTION V: ANTIHYPERTENSIVE THERAPY20. Diuretics Therapy21. Calcium Channel Blockers22. Renin Angiotensin Aldosterone System Blockers23. Aldosterone and Hypertension24. ß-Blockers, Central Sympathetic Agents,and Direct Vasodilators25. Peripheral Alpha Blockers26. Initial Combination Therapies27. Devices Therapies for Hypertension28. The Treatment of Hypertension With Nutrition, Nutritional Supplements, and LifestyleSECTION VI: HYPERTENSION MANAGEMENT APPROACHES29. Approach to Difficult to Manage Primary Hypertension30. Team-Based Care for Hypertension Management31. Medication Adherence: Focus on Improvement32. Digital Health and Telemedicine for HypertensionSECTION VII HYPERTENSION MANAGEMENT WITH COMORBIDITIES33. Ischemic Heart Disease34. Heart Failure35. Hypertension and Chronic Kidney Disease Including Dialysis36. Transplant Hypertension37. Obesity and Hypertension: Pathophysiology and Treatment38. Cerebrovascular Disease39. Diabetes Mellitus: Management of Hypertension in Diabetes40. Onco-Hypertension: Anticancer Therapy-Associated Hypertension41. Autonomic Dysfunction and Orthostatic Hypotension42. Dyslipidemia43. Aorta and Peripheral Arterial Disease in HypertensionSECTION VIII SPECIAL POPULATIONS44. Hypertension in Pregnancy45. Hypertension in Older People46. Hypertension in African Americans47. Resistant Hypertension48. Hypertensive Emergencies and Urgencies49. Hypertension in Children: Diagnosis and TreatmentAppendix Meta-Analyses of Blood Pressure Lowering Trials